KD
Kerry Dobbs
Also known as: A. Kerry Dobbs, Adam Kerry Dobbs
JURA Bio, Inc. (United States), National Institutes of Health, Mississippi State University, Boston Children's Hospital
Research areas: Immunology and Microbiology · Immunology · Immunodeficiency and Autoimmune Disorders · T-cell and B-cell Immunology · SARS-CoV-2 and COVID-19 Research
0000-0002-3432-3137
Employment
-
JURA Bio, Inc. Co-Head of Research and Development2025 - Present
-
National Institutes of Health Special Volunteer2021 - 2025
-
JURA Bio, Inc. Research Scientist and Head of Laboratory Operations2021 - 2025
-
National Institutes of Health Biologist2016 - 2021
-
Children's Hospital Boston Research Technologist2012 - 2016
-
St. Jude Children's Research Hospital Laboratory Technologist2004 - 2011
Education
-
Mississippi State University Bachelor of Science1999 - 2003
Projects & Funding
Projects & funding information is unavailable.
Publications (55)
- Manufacturing-aware generative models enable petascale synthesis of designed DNA Save
- Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature Save
- Manufacturing-Aware Generative Model Architectures Enable Biological Sequence Design and Synthesis at Petascale Save
- Embryonic lymphocytes contribute to a genetic form of autoimmune inflammation Save
- Encephalitis and poor neuronal death–mediated control of herpes simplex virus in human inherited RIPK3 deficiency Save
- A Heterozygous Gain-of-Function Variant in IKBKB Associated with Autoimmunity and Autoinflammation Save
- Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19 Save
- Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality Save
- SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation Save
- Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab Save
- Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19 Save
- Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility Save
- Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Save
- Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia Save
- PAX1 is essential for development and function of the human thymus Save
- Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome Save
- Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis. Save
- Defining a new immune deficiency syndrome: MAN2B2-CDG. Save
- Severe influenza pneumonitis in children with inherited TLR3 deficiency Save
- From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies. Save